What's in Sherif Mohamed Abd el moneim Soaida, MD's pipeline?

Sherif Mohamed Abd el moneim Soaida, MD has 3 drugs in our index: 3 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Sherif Mohamed Abd el moneim Soaida, MD's portfolio?

No competitive overlap detected.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/sherif-mohamed-abd-el-moneim-soaida-md.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Sherif Mohamed Abd el moneim Soaida, MD — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Sherif Mohamed Abd el moneim Soaida, MD pipeline: 3 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

3 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Perineural Dexamethasone and bupivacaine	Perineural Dexamethasone and bupivacaine	marketed	Local anesthetic with adjuvant corticosteroid	Voltage-gated sodium channels (bupivacaine); glucocorticoid receptor (dexamethasone)	Anesthesia/Pain Management
Systemic Dexamethasone plus perineural bupivacaine	Systemic Dexamethasone plus perineural bupivacaine	marketed	Combination therapy: corticosteroid + local anesthetic	Glucocorticoid receptor (dexamethasone); voltage-gated sodium channels (bupivacaine)	Pain management / Regional anesthesia
intravenous saline plus perineural bupivacaine	intravenous saline plus perineural bupivacaine	marketed	Local anesthetic with supportive fluid therapy	Voltage-gated sodium channels (Nav)	Anesthesia and Pain Management

Therapeutic area mix

Anesthesia and Pain Management · 1
Anesthesia/Pain Management · 1
Pain management / Regional anesthesia · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

No competitive overlap data.

Subscribe to ongoing alerts

Every new pipeline event for Sherif Mohamed Abd el moneim Soaida, MD:

Cite this brief

Drug Landscape (2026). Sherif Mohamed Abd el moneim Soaida, MD — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/sherif-mohamed-abd-el-moneim-soaida-md. Accessed 2026-05-17.